Certified by Founder Lodge
Lumira Ventures
Canada - Toronto, Ontario
INVESTOR
1 Disclosed Funding Rounds $53,000,000
16 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Lumira Ventures invests in transformative biopharmaceutical, medical device and digital health companies located in North America. We are engaged partners who support the management teams of
| Company | Date | Round | Raised |
|---|---|---|---|
 HistoSonics, Inc. |
August, 16 ,2024 | Series D | $102,000,000 |
 Antiva Biosciences, Inc. |
April, 27 ,2023 | Series E | $53,000,000 |
 SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
 Alpha-9 Oncology |
October, 24 ,2024 | Series C | $175,000,000 |
 Specific Biologics |
October, 17 ,2023 | Unknown | |
 Axonis Therapeutics |
October, 31 ,2024 | Series A | $115,000,000 |
| Alpha-9 Oncology |
October, 24 ,2024 | Series C | $175,000,000 |
 XyloCor Therapeutics, Inc. |
January, 09 ,2025 | Series B | $67,500,000 |
 Cyrano Therapeutics |
January, 17 ,2024 | Series B | $9,000,000 |
 Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
| HistoSonics, Inc. |
August, 16 ,2024 | Series D | $102,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Alpha-9 Oncology |
October, 24 ,2024 | Series C | $175,000,000 |
| Axonis Therapeutics |
October, 31 ,2024 | Series A | $115,000,000 |
| XyloCor Therapeutics, Inc. |
January, 09 ,2025 | Series B | $67,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
